Measurement of glycine in human prefrontal brain by point‐resolved spectroscopy at 7.0 tesla in vivo

Measurement of glycine in human frontal brain by an optimized point‐resolved spectroscopy sequence at 7 T is reported. Echo time dependencies of the overlapping coupled resonances of myo‐inositol, free choline, and threonine were investigated with density matrix simulations, incorporating the slice‐selective radiofrequency and gradient pulses. The numerical simulations indicated that the selectivity of the 3.55‐ppm glycine singlet is maximized at (TE1, TE2) = (101, 51) ms. Phantom experiments indicated that the myo‐inositol peak amplitude between 3.5 and 3.6 ppm is reduced by a factor of 30 following the optimized point‐resolved spectroscopy, as predicted by the simulation. From LCModel analyses, the glycine concentration in the medial prefrontal cortex in healthy adults was estimated, with a mean Cramér‐Rao lower bound of 7 ± 1% (mean ± standard deviation; n = 7), to be 0.8 ± 0.1 mM, with reference to total creatine at 8 mM. Magn Reson Med, 2009. © 2009 Wiley‐Liss, Inc.

[1]  V. Govindaraju,et al.  Proton NMR chemical shifts and coupling constants for brain metabolites , 2000, NMR in biomedicine.

[2]  Editing through multiple bonds: Threonine detection , 2008, Magnetic resonance in medicine.

[3]  I. Nimmo-Smith,et al.  Hypofrontality in schizophrenia: a meta‐analysis of functional imaging studies , 2004, Acta psychiatrica Scandinavica.

[4]  Peter Andersen,et al.  Proton T2 relaxation study of water, N‐acetylaspartate, and creatine in human brain using Hahn and Carr‐Purcell spin echoes at 4T and 7T , 2002, Magnetic resonance in medicine.

[5]  Chenguang Zhao,et al.  In vivo detection of serine in the human brain by proton magnetic resonance spectroscopy (1H‐MRS) at 7 Tesla , 2009, Magnetic resonance in medicine.

[6]  G B Matson,et al.  An integrated program for amplitude-modulated RF pulse generation and re-mapping with shaped gradients. , 1994, Magnetic resonance imaging.

[7]  Mathias Hoehn,et al.  Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation , 2005, NMR in biomedicine.

[8]  Daniel C Javitt,et al.  Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. , 2007, International review of neurobiology.

[9]  Wietske van der Zwaag,et al.  In vivo measurement of glycine with short echo-time 1H MRS in human brain at 7 T , 2009, Magnetic Resonance Materials in Physics, Biology and Medicine.

[10]  S. Rauch,et al.  Neurobiology of emotion perception II: implications for major psychiatric disorders , 2003, Biological Psychiatry.

[11]  P. Legendre.  The glycinergic inhibitory synapse , 2001, Cellular and Molecular Life Sciences CMLS.

[12]  M. A. Samphilipo,et al.  Quantitative proton spectroscopy of canine brain: in Vivo and in Vitro correlations , 1994, Magnetic resonance in medicine.

[13]  P. Allen,et al.  Proton spectral editing for discrimination of lactate and threonine 1.31 ppm resonances in human brain in vivo , 2006, Magnetic resonance in medicine.

[14]  H. Betz,et al.  Glycine transporters: essential regulators of neurotransmission. , 2005, Trends in biochemical sciences.

[15]  P. Renshaw,et al.  In vivo detection of brain glycine with echo‐time‐averaged 1H magnetic resonance spectroscopy at 4.0 T , 2006, Magnetic resonance in medicine.

[16]  S. Provencher.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[17]  Peter Boesiger,et al.  ProFit: two‐dimensional prior‐knowledge fitting of J‐resolved spectra , 2006, NMR in biomedicine.

[18]  S. Kalra,et al.  Measurement of glycine in human brain by triple refocusing 1H‐MRS in vivo at 3.0T , 2008, Magnetic resonance in medicine.